Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA SUVEN LIFE SCIENCES ORCHID PHARMA/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 41.8 -20.5 - View Chart
P/BV x 7.7 5.8 132.9% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ORCHID PHARMA   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    ORCHID PHARMA
Mar-23
SUVEN LIFE SCIENCES
Mar-23
ORCHID PHARMA/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs43994 467.7%   
Low Rs27345 606.8%   
Sales per share (Unadj.) Rs163.10.6 26,275.1%  
Earnings per share (Unadj.) Rs13.5-5.4 -249.6%  
Cash flow per share (Unadj.) Rs27.0-5.1 -526.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs168.717.2 980.2%  
Shares outstanding (eoy) m40.82218.07 18.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.2111.8 2.0%   
Avg P/E ratio x26.3-12.8 -205.5%  
P/CF ratio (eoy) x13.2-13.5 -97.5%  
Price / Book Value ratio x2.14.0 52.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m14,52215,131 96.0%   
No. of employees `000NANA-   
Total wages/salary Rs m654186 350.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6,659135 4,918.4%  
Other income Rs m19484 230.0%   
Total revenues Rs m6,853220 3,116.8%   
Gross profit Rs m1,235-1,196 -103.2%  
Depreciation Rs m54865 837.3%   
Interest Rs m3295 6,115.6%   
Profit before tax Rs m552-1,183 -46.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m00-   
Profit after tax Rs m552-1,183 -46.7%  
Gross profit margin %18.5-883.6 -2.1%  
Effective tax rate %00-   
Net profit margin %8.3-873.5 -0.9%  
BALANCE SHEET DATA
Current assets Rs m5,0103,455 145.0%   
Current liabilities Rs m3,7191,050 354.1%   
Net working cap to sales %19.41,776.0 1.1%  
Current ratio x1.33.3 41.0%  
Inventory Days Days573,948 1.5%  
Debtors Days Days1,180218 541.9%  
Net fixed assets Rs m7,2421,373 527.4%   
Share capital Rs m408218 187.2%   
"Free" reserves Rs m6,4783,535 183.3%   
Net worth Rs m6,8863,753 183.5%   
Long term debt Rs m1,4880-   
Total assets Rs m12,2524,828 253.8%  
Interest coverage x2.7-218.8 -1.2%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.50 1,938.1%   
Return on assets %7.2-24.4 -29.5%  
Return on equity %8.0-31.5 -25.5%  
Return on capital %10.5-31.4 -33.6%  
Exports to sales %81.940.4 202.4%   
Imports to sales %37.6839.8 4.5%   
Exports (fob) Rs m5,45255 9,957.5%   
Imports (cif) Rs m2,5011,137 220.0%   
Fx inflow Rs m5,45255 9,957.5%   
Fx outflow Rs m2,7261,137 239.7%   
Net fx Rs m2,726-1,082 -251.9%   
CASH FLOW
From Operations Rs m183-1,031 -17.8%  
From Investments Rs m-312-2,606 12.0%  
From Financial Activity Rs m3123,955 7.9%  
Net Cashflow Rs m183317 57.6%  

Share Holding

Indian Promoters % 69.8 69.6 100.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 18.6 0.6 3,389.1%  
FIIs % 4.1 0.5 766.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.2 30.4 99.1%  
Shareholders   36,931 74,003 49.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Orchid Pharma vs Suven Life Sciences

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Orchid Pharma vs Suven Life Sciences Share Price Performance

Period Orchid Pharma Suven Life Sciences S&P BSE HEALTHCARE
1-Day -0.40% 0.30% 1.18%
1-Month -14.06% -2.06% -0.75%
1-Year 173.54% 114.92% 61.82%
3-Year CAGR -23.64% 14.94% 18.16%
5-Year CAGR 184.58% -16.22% 19.79%

* Compound Annual Growth Rate

Here are more details on the Orchid Pharma share price and the Suven Life Sciences share price.

Moving on to shareholding structures...

The promoters of Orchid Pharma hold a 69.8% stake in the company. In case of Suven Life Sciences the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Orchid Pharma and the shareholding pattern of Suven Life Sciences.

Finally, a word on dividends...

In the most recent financial year, Orchid Pharma paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Orchid Pharma, and the dividend history of Suven Life Sciences.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.